Actively Recruiting
Evaluating Stereotactic Body Radiation Therapy for Spinal Metastases with Epidural Spinal Cord Compression Bilsky Grade 1c-3 in a Prospective Single-Arm Study
Led by Tianjin Medical University Cancer Institute and Hospital · Updated on 2026-09-09
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of stereotactic body radiation therapy SBRT in treating patients with spinal metastases who have epidural spinal cord compression classified as Bilsky grade 1c-3. This phase II clinical trial is designed as a prospective, multicenter, single-arm study to better understand SBRTs impact on this patient group. Participants will receive SBRT using the CyberKnife system. Treatment is administered once daily, over a period of 1 to 2 weeks. The study focuses on patients with spinal metastases confirmed by MRI, specifically those with Bilsky grade 1c-3 compression, and limits the number of affected vertebral segments to three or fewer. During the trial, participants will be monitored for local failure of the treated area up to 12 months after treatment starts, as well as overall survival during the same period. Researchers will assess patient health through imaging, laboratory tests, and clinical evaluations to track treatment effects and safety. The total study duration extends until September 2028, allowing for comprehensive follow-up.
CONDITIONS
Brief Title
Efficacy and Safety of Stereotactic Body Radiation Therapy for Spinal Metastases With Bilsky Grade 1c-3
Research Team
H
Huanhuan Wang, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here